Impact of Arterial Hypertension on Left Atrial Size and Function

Table 3

Variation of LA maximal volume according to demographic and clinical parameters.

Variables		LA maximal volume increased
		Effective (percentage)	value
Age group	40-49	01 (11,1%)	N/A
	50–59	06 (36,7%)
	60-69	01 (11,1%)
	70-79	01 (11,1%)
Genre	Men	04 (44,4%)	0,3
	Women	05 (55,6%)
Grade AHT	I	0 (0%)	N/A
	II	06 (66,7%)
	III	03 (33,3%)
Diabetes	Yes	01 (11,1%)	0,037
	No	08 (88,9%)
Dyslipidemia	YES	01 (11,1%)	0,36
	No	08 (88,9%)
Sedentarite	Yes	03 (33,3%)	0,4
	No	06 (66,6%)
Obesity	Yes	03 (33,3%)	0,33
	No	06 (66,6%)
Smoking	Yes	01 (11,1%)	0,52
	No	08 (88,9%)
Coronary heredity	Yes	01 (11,1%)	0,24
	No	08 (88,9%)
Menopause	Yes	01 (11,1%)	0,54
	No	08 (88,9%)
CA	Yes	01 (11,1%)	0,42
	No	08 (88,9%)
ACE	Yes	02 (22,2%)	0,29
	No	07 (77,8%)
ARAII	Yes	01 (11,1%)	0,58
	No	08 (88,9%)
BB	Yes	00 (0%)	0,61
	No	09 (100%)
Diastolic dysfunction	I	04 (44,44%)	N/A
	II	01 (11,11%)
	III	04 (44,44%)
	Undetermined	0 (0%)
LVH	Yes	07 (77,8%)	N/A
	No	02 (22,2%)

CA: calcium antagonists; ACE: angiotensin-converting enzyme; ARAII: angiotensin II receptor antagonists; BB: beta-blockers; N/A: not applicable; LVH: left ventricular hypertrophy.